The bar was raised for markets to rally following an announcement by Pfizer Inc. that its vaccine protected 90 per cent of Covid-19 cases in a study, investors and strategists said. Moderna’s version, which uses similar experimental messenger RNA technology, is due to report results imminently.
– Stocks-Markets-Economic Times
